Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03718767
Title Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors National Cancer Institute (NCI)
Indications

high grade glioma

Therapies

Nivolumab

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST